Drug of choice for generalized anxiety disorder –
Wait, the question is about the drug of choice. So first-line would be SSRIs and SNRIs. Between those, maybe SSRIs are more commonly prescribed first. Let me check the options again. The user didn't provide the options, but the correct answer is supposed to be one of them. Let's assume the options include SSRIs, SNRIs, benzodiazepines, and maybe others like buspirone or TCAs.
The core concept here is the pharmacological management of GAD. The first-line drugs are SSRIs and SNRIs because they have a better safety profile and are effective. Benzodiazepines are effective but have risks of dependence. Buspirone is an anxiolytic but takes longer to work. TCAs are older and have more side effects.
So the correct answer would be an SSRI like sertraline or paroxetine. If the options include those, then that's the right choice. The incorrect options would be benzodiazepines because they're not first-line for long-term use, TCAs for their side effects, and maybe antipsychotics which aren't standard.
The clinical pearl is that SSRIs/SNRIs are first-line for GAD due to efficacy and safety. A mnemonic could be "SSRIs and SNRIs before benzodiazepines." Also, remember that benzodiazepines are for acute symptoms but not long-term management because of dependence risk.
Putting it all together, the correct answer is the SSRI or SNRI in the options. The explanation should highlight why those are preferred over the alternatives. Each wrong option's flaws need to be addressed briefly but clearly.
**Core Concept**
Generalized anxiety disorder (GAD) is managed with selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) as first-line agents. These drugs modulate serotonin and norepinephrine pathways, which are dysregulated in anxiety disorders. Benzodiazepines are reserved for short-term relief due to dependence risks.
**Why the Correct Answer is Right**
SSRIs like **sertraline** or **paroxetine**, and SNRIs like **venlafaxine**, are first-line for GAD due to their efficacy in reducing symptoms over weeks. They work by increasing synaptic serotonin (SSRIs) or both serotonin and norepinephrine (SNRIs), enhancing mood and anxiety regulation. These agents have a favorable safety profile, minimal sedation, and no abuse potential, making them superior to benzodiazepines for long-term use.
**Why Each Wrong Option is Incorrect**
**Option A:** *Benzodiazepines* (e.g., alprazolam) are not first-line due to rapid tolerance, dependence, and cognitive impairment.
**Option B:** *Tricyclic antidepress